{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-029613","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.140702+00:00","generated_at":"2026-05-17T16:59:33.511735+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nu Skin Q2 EPS $0.43 beats guidance; raises FY EPS outlook to $3.05-$3.25","bullets":["Revenue $386.1M, down 12% YoY; EPS $0.43 (adj. $0.21) vs ($2.38) prior year.","Operating margin 8.0% (vs (28.6)%); positive net cash position achieved for first time in >4 years.","Customers 771K (-14%), Sales Leaders 29.6K (-23%), Paid Affiliates 130.8K (-16%).","Rhyz Manufacturing segment +17% YoY; Latin America revenue +107% YoY.","FY 2025 guidance narrowed: rev $1.48-$1.55B; EPS raised to $3.05-$3.25 (adj. $1.15-$1.35)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-029613","json":"https://secwatch.observer/filing/0001140361-25-029613.json","markdown":"https://secwatch.observer/filing/0001140361-25-029613.md","text":"https://secwatch.observer/filing/0001140361-25-029613.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036125029613/0001140361-25-029613-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036125029613/ef20053399_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T16:59:33.511735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}